Anti-tumor immune function of NR2F6, an orphan nuclear receptor, in stromal cells

被引：0
|
作者：
Kim, Hyungsoo
Feng, Yongmei
Radaeva, Marria
Sergienko, Eduard
Cherkasov, Artem
Ronai, Ze'ev A.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-6531
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6531
引用
收藏
页数：2
相关论文
共 50 条
  • [41] The Orphan Nuclear Receptor TLX/NR2E1 in Neural Stem Cells and Diseases
    Wang, Tao
    Xiong, Jian-Qiong
    NEUROSCIENCE BULLETIN, 2016, 32 (01) : 108 - 114
  • [42] The Orphan Nuclear Receptor TLX/NR2E1 in Neural Stem Cells and Diseases
    Tao Wang
    Jian-Qiong Xiong
    Neuroscience Bulletin, 2016, 32 : 108 - 114
  • [43] Modulation of Nr2f2 reprograms tumor blood vessels to enhance anti-tumor immunity and immunotherapy.
    Zhu, Yu
    Lazarus, Nicole
    Brulois, Kevin
    Salazar, Nicole
    Dinh, Theresa
    Pan, Junliang
    Butcher, Eugene
    CANCER RESEARCH, 2021, 81 (13)
  • [44] Mesenchymal stromal cells inhibit murine syngeneic anti-tumor immune responses by attenuating inflammation and reorganizing the tumor microenvironment
    Modiano, Jaime F.
    Lindborg, Beth A.
    McElmurry, Ron T.
    Lewellen, Mitzi
    Forster, Colleen L.
    Zamora, Edward A.
    Schaack, Jerome
    Bellgrau, Donald
    O'Brien, Timothy D.
    Tolar, Jakub
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2015, 64 (11) : 1449 - 1460
  • [45] Mesenchymal stromal cells inhibit murine syngeneic anti-tumor immune responses by attenuating inflammation and reorganizing the tumor microenvironment
    Jaime F. Modiano
    Beth A. Lindborg
    Ron T. McElmurry
    Mitzi Lewellen
    Colleen L. Forster
    Edward A. Zamora
    Jerome Schaack
    Donald Bellgrau
    Timothy D. O’Brien
    Jakub Tolar
    Cancer Immunology, Immunotherapy, 2015, 64 : 1449 - 1460
  • [46] NR2F6, a new immune checkpoint that acts as a potential biomarker of immunosuppression and contributes to poor clinical outcome in human glioma
    Miftah, Hayat
    Naji, Oumayma
    Ssi, Saadia Ait
    Ghouzlani, Amina
    Lakhdar, Abdelhakim
    Badou, Abdallah
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [47] Chimeric NKG2D receptor expressing T cells require host immune cells for anti-tumor efficacy
    Barber, Amorette
    Zhang, Tong
    Sentman, Charles L.
    FASEB JOURNAL, 2008, 22
  • [48] Regulation of Anti-Tumor Immune Response by EphA2 Receptor Tyrosine Kinase
    Shi, Xioajun Roger
    Lingerak, Ryan
    Kim, Soyeon
    Wang, Bingcheng
    CANCER IMMUNOLOGY RESEARCH, 2025, 13 (02)
  • [49] Regulation of the Orphan Nuclear Receptor Nr2f2 by the DFNA15 Deafness Gene Pou4f3
    Tornari, Chrysostomos
    Towers, Emily R.
    Gale, Jonathan E.
    Dawson, Sally J.
    PLOS ONE, 2014, 9 (11):
  • [50] TGF-β-responsive CAR-T cells promote anti-tumor immune function
    Hou, Andrew J.
    Chang, ZeNan L.
    Lorenzini, Michael H.
    Zah, Eugenia
    Chen, Yvonne Y.
    BIOENGINEERING & TRANSLATIONAL MEDICINE, 2018, 3 (02) : 75 - 86
12345